Covid-19 vaccine, with developments that could lead to some Americans getting inoculated in the final days of 2020.Pfizer Inc.
and German partner BioNTech SE this month plan to reveal late-stage results showing whether or not their two-shot regimen is effective in preventing the spread of the virus.“This could be a key catalyst for not only the companies, but the entire market," JPMorgan analyst Cory Kasimov said.Another potential market-moving event comes on Oct.
22. A Food and Drug Administration advisory committee made up of outside experts is likely to review new results and updates on trial enrollments as well as hash out distribution plans.
Read more on livemint.com